Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ivonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer — Stella

Recruiting

Back to Non-Small Cell Lung Cancer trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Shanghai East Hospital, Shanghai, Shanghai Municipality

Key details

Phase

Large-scale testing

Sponsor

Akeso

Enrollment target

~536 participants

Started

July 2025

Primary completion

May 2027

Age range

18 Years – 75 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov